Cosmic Crypto ClubCosmic Crypto Club
Home
Markets
Tools
Academy
Brokers
DiscordLaunch Hub
Cosmic Crypto Club

Free trading education, market data & a community of serious traders. Join thousands learning to trade Crypto, Forex & Stocks.

Markets

  • Market Overview
  • Cryptocurrencies
  • Stocks
  • Forex
  • Indices
  • Commodities
  • News

Tools & Software

  • All Tools
  • Calculators
  • Screener
  • Economic Calendar
  • Trading Journal
  • Trading Software

Academy

  • Academy Home
  • Strategies
  • Glossary
  • How-To Guides
  • DeFi Protocols
  • Tax Guides

Brokers & Company

  • All Brokers
  • Crypto Exchanges
  • Prop Firms
  • About Us
  • Contact
  • FAQ

© 2026 Cosmic Crypto Club. All rights reserved.

Terms of ServicePrivacy PolicyCookie PolicyAffiliate DisclosureRisk & Investment Disclaimer

The information on cosmiccrypto.club is provided for general information purposes only. It does not constitute legal, financial, or professional advice. Cosmiccrypto.club does not accept responsibility for any loss or damage arising from reliance on the site's content. Users should seek independent advice and information before making financial decisions. Trading cryptocurrencies, stocks, and other financial instruments involves substantial risk and may not be suitable for every investor.

Back to Stocks
IMVT
Rank #1243IMVT

Immunovant, Inc.

$26.36

-1.09% (Daily)

Market Cap

$5.37B

Revenue

$N/A

Rank by MCap

#1243

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Frank M. Torti M.B.A., M.D.

Headquarters

New York, NY

Employees

362

About Immunovant, Inc.

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, ...

Immunovant, Inc. Price Chart

Loading chart…

Community & Socials

Website

Explore Related

Browse ETFsExplore CryptocurrencyView All S&P 500 Stocks